These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 6435513)

  • 1. Correlation between lipopolysaccharide structure and permeability resistance in beta-lactam-resistant Pseudomonas aeruginosa.
    Godfrey AJ; Hatlelid L; Bryan LE
    Antimicrob Agents Chemother; 1984 Aug; 26(2):181-6. PubMed ID: 6435513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipopolysaccharide alterations responsible for combined quinolone and beta-lactam resistance in Pseudomonas aeruginosa.
    Leying HJ; Büscher KH; Cullmann W; Then RL
    Chemotherapy; 1992; 38(2):82-91. PubMed ID: 1591950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-lactam resistant Pseudomonas aeruginosa strains emerging during therapy: synergistic resistance mechanisms.
    Pagani L; Debiaggi M; Tenni R; Cereda PM; Landini P; Romero E
    Microbiologica; 1988 Jan; 11(1):47-53. PubMed ID: 2832709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of susceptibility and resistance of bacteria to beta-lactam antibiotics].
    Tsuji A
    Nihon Rinsho; 1991 Oct; 49(10):2254-60. PubMed ID: 1749080
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of permeability barriers in resistance to beta-lactam antibiotics.
    Nikaido H
    Pharmacol Ther; 1985; 27(2):197-231. PubMed ID: 2412244
    [No Abstract]   [Full Text] [Related]  

  • 6. [Actions of beta-lactam antibiotics against Pseudomonas aeruginosa: their effects on penicillin-binding proteins and on bactericidal activity of macrophages].
    Nakamuta S
    Nihon Hinyokika Gakkai Zasshi; 1983 Dec; 74(12):2031-42. PubMed ID: 6429401
    [No Abstract]   [Full Text] [Related]  

  • 7. Emergence of resistance to beta-lactam antibiotics in Pseudomonas aeruginosa during treatment with new beta-lactams.
    Lerner SA; Quinn JP
    Chemioterapia; 1985 Feb; 4(1):95-101. PubMed ID: 3921267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of beta-lactamase in in vivo development of ceftazidime resistance in experimental Pseudomonas aeruginosa endocarditis.
    Bayer AS; Peters J; Parr TR; Chan L; Hancock RE
    Antimicrob Agents Chemother; 1987 Feb; 31(2):253-8. PubMed ID: 3105450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of the MexAB-OprM multidrug efflux system to the beta-lactam resistance of penicillin-binding protein and beta-lactamase-derepressed mutants of Pseudomonas aeruginosa.
    Srikumar R; Tsang E; Poole K
    J Antimicrob Chemother; 1999 Oct; 44(4):537-40. PubMed ID: 10588316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penicillin-binding proteins of Pseudomonas aeruginosa. Comparison of two strains differing in their resistance to beta-lactam antibiotics.
    Curtis NA; Orr D; Boulton MG; Ross GW
    J Antimicrob Chemother; 1981 Feb; 7(2):127-36. PubMed ID: 6783607
    [No Abstract]   [Full Text] [Related]  

  • 11. Permeability and penicillin-binding protein alterations in Salmonella muenchen: stepwise resistance acquired during beta-lactam therapy.
    Bellido F; Vladoïanu IR; Auckenthaler R; Suter S; Wacker P; Then RL; Pechère JC
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1113-5. PubMed ID: 2782862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penicillin-binding proteins, porins and outer-membrane permeability of carbenicillin-resistant and -susceptible strains of Pseudomonas aeruginosa.
    Livermore DM
    J Med Microbiol; 1984 Oct; 18(2):261-70. PubMed ID: 6092639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta-Lactam-resistant Pseudomonas aeruginosa with modified penicillin-binding proteins emerging during cystic fibrosis treatment.
    Godfrey AJ; Bryan LE; Rabin HR
    Antimicrob Agents Chemother; 1981 May; 19(5):705-11. PubMed ID: 6457554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of porin proteins OmpF and OmpC in the permeation of beta-lactams.
    Jaffe A; Chabbert YA; Semonin O
    Antimicrob Agents Chemother; 1982 Dec; 22(6):942-8. PubMed ID: 6760806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invalidity for Pseudomonas aeruginosa of an accepted model of bacterial permeability to beta-lactam antibiotics.
    Livermore DM; Davy KW
    Antimicrob Agents Chemother; 1991 May; 35(5):916-21. PubMed ID: 1906695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penicillin binding proteins and resistance to beta-lactam antibiotics in Staphylococcus aureus.
    Fontana R; Rossi L; Rong YC; Tonin E
    Chemioterapia; 1985 Feb; 4(1):53-5. PubMed ID: 3986945
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanisms of resistance to beta-lactam antibiotics in Acinetobacter calcoaceticus.
    Obara M; Nakae T
    J Antimicrob Chemother; 1991 Dec; 28(6):791-800. PubMed ID: 1816177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outer membrane proteins responsible for the penetration of beta-lactams and quinolones in Pseudomonas aeruginosa.
    Yamano Y; Nishikawa T; Komatsu Y
    J Antimicrob Chemother; 1990 Aug; 26(2):175-84. PubMed ID: 2120174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-lactam-fosfomycin antagonism involving modification of penicillin-binding protein 3 in Pseudomonas aeruginosa.
    Reguera JA; Baquero F; Berenguer J; Martinez-Ferrer M; Martinez JL
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2093-6. PubMed ID: 2127343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration of beta-lactams through Pseudomonas aeruginosa porin channels.
    Godfrey AJ; Bryan LE
    Antimicrob Agents Chemother; 1987 Aug; 31(8):1216-21. PubMed ID: 2443074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.